SERRG, Inc was recently featured on WTVM – 9 Columbus to discuss a current clinical research trial for a new drug to treat staph infections. Dr. Joseph Surber and Dr. Jeff Kingsley are hosting this double-blind study to research the new antibiotic. Research in this area is critical because more and more staph infections are becoming resistant to current medical treatments.

Approximately 700 patients are needed for the study, and participation is free of charge. If the research drug is successful, it could potentially be on the market in a few years. Watch the video to find out more about the study.

This entry was posted on Tuesday, August 28th, 2007 at 4:38 pm and is filed under Media.